About us

OncoOne is a biotech start-up dedicated to develop innovative therapeutics to treat patients with solid tumors, founded by three individuals with a long history in industrial drug development and oncology research.

The aim of OncoOne is to be a research engine for anti-cancer medicines that meet serious unmet medical needs in oncology. Our passion for science is at the core of everything we do to build a differentiated pipeline of potent therapeutics. Our entrepreneurial spirit enables us to link innovation with corporate strategies.


Meet our COO

Meet our COO Michael Thiele at the 4th Drug Discovery Strategic Summit (October 17-18 2019, Munich Germany).

We are a team of experienced professionals.

Randolf Kerschbaumer, PhD

Founder & Chief Executive Officer

Randolf has more than 20 years of experience in academic and big pharma R&D and acquired detailed knowledge of the entire drug development process, from early drug screening to clinical development. He is in charge of executive management, fundraising, patenting and business development.

Michael Thiele, PhD

Founder & Chief Operating Officer

Michael is a renowned expert in immunology, tumor biology, biomarker and the development of biologics. He is responsible for establishing and managing external collaborations and our primary contact for our CROs and external partners.

Alexander Schinagl, PhD

Founder & Chief Scientific Officer

Alexander has a broad knowledge in molecular biology, biochemistry and cell biology techniques in the field of oncology and inflammation. He is responsible for lab management and continuously improves our in-house capabilities and technologies.

What would be a team without excellent partners.